Back

Optimal ranges for maternal serum potassium and sodium: associations with hypertensive risks and major adverse pregnancy outcomes

29 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Addressing comorbidities during pregnancy Pregnancy and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Fang Yiwen

Tianjin (China)

6 More presentations in this session

Presentation thumbnail
Pregnancy outcomes and risk factors for adverse cardiac events in women with congenital heart disease complicated by pulmonary hypertension
Doctor X. Gu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Hypertensive disorders in pregnancy as risk factors for aortic valve calcification and aortic aneurysm in middle age; a Swedish cohort study
Doctor K. Bergman (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
The importance of global area strain in the assessment of the left ventricular systolic function in hypertensive pregnancy
Associate Professor A. Ilic (Novi Sad, RS)
Abstract Slides Video
Presentation thumbnail
Subclinical atherosclerosis in women who have had preeclampsia: a systematic review and meta analysis
Doctor J. Yao (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Incidence and outcomes of critically ill obstetric patients with heart diseases: a retrospective study from a tertiary care centre
Doctor P. Sharma (Lucknow, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Addressing comorbidities during pregnancy

The Event

Event poster

ESC Congress 2025

29 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Independent and joint associations of urinary potassium excretion with cardiovascular death: a national population-based cohort study
thumbnail
Congress Presentation
Distinct risk patterns of mid-trimester systolic-diastolic blood pressure for individual and co-occurring adverse pregnancy outcomes
thumbnail
Congress Presentation
Unlocking survival: assessment of potassium levels in heart failure with quadruple guideline directed medical therapy across all ejection fraction spectrum

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources